Early research (Phase 1)Study completedNCT00077454
What this trial is testing
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors
Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more
National Cancer Institute (NCI) 95